Skip to main content
. 2021 Sep 20;8:678614. doi: 10.3389/fcvm.2021.678614

Table 1.

Baseline characteristics of patients with HFmrEF and HFpEF.

Characteristics Chioncel et al. (3) Wang et al. (5) Tsuji et al. (14) Lund et al. (13) Moliner et al. (15)
HFmrEF HFpEF HFmrEF HFpEF HFmrEF HFpEF HFmrEF HFpEF HFmrEF HFpEF
n = 2,212 n = 1,462 n = 6,825 n = 13,497 n = 596 n = 2,154 n = 1,322 n = 1,953 n = 134 n = 135
Age (years) 64.2 ± 14.2 68.6 ± 13.7 67.7 ± 13.3 71.3 ± 12.5 69.0 ± 11.6 71.7 ± 10.9 65 ± 11 67 ± 11 67 ± 12 69.6 ± 14.4
Female gender (%) 31.5 47.9 35.2 50.2 28.2 39.2 29.9 45.5 32.1 60.7
BMI (kg/m2) 28.6 ± 5.4 28.4 ± 5.4 24.0 ± 4.0 24.2 ± 4.2 22.8 ± 5.3 23.2 ± 4.7 27.8 (25.0–31.2) 28.6 (25.4–32.6) 28.6 ± 5.4 28.6 ± 5.4
SBP (mmHg) 126.5 ± 21.1 130.98 ± 21.4 131.3 ± 22.4 134.9 ± 22.9 124.7 ± 19.3 127.9 ± 19.2 130 (120–145) 140 (124–150) 132.4 ± 20.6 135.4 ± 25.7
NYHA class III–IV, n (%) 18.4 20.3 36.2 41.6 11.7 10.6 42.3 38.9 28.4 34.8
IHD (%) 41.8 23.7 60.8 57.1 52.9 44.1 66.9 50.4 54.5 13.3
DCM (%) 27.6 11.6 10.6 2.9 20.3 6.4 6.7 1.5
Hypertension (%) 9.6 18.1 59.4 64.5 89.8 91.2 56.2 68.7 66.4 74.8
AF (%) 22.3 32.2 33.0 40.9 43.5 51.8 25.6 31.3 22.4 38.5
DM (%) 30.5 29.3 30.7 28.5 36.1 33.8 28.6 28.1 29.9 37.8
MI 39.4 22.4 41.1 26.9 57.6 37.0
COPD (%) 11.6 14.0 7.4 9.6
Prior stroke/TIA (%) 8.3 9.8 14.6 17.5 22.1 21.9 9.3 8.4
Chronic kidney disease (%) 16.5 19.9 11.9 11.0
LBBB (%) 15.4 8.7 5.0 2.3
Anemia 28.5 31.7

AF, atrial fibrillation/flutter; BMI, body mass index; COPD, chronic pulmonary obstructive disease; DCM, dilated cardiomyopathy; DM, diabetes mellitus; IHD, ischemic heart disease; LBBB, left bundle branch block; MI, myocardial infarction; NYHA, New York Heart Association; SBP, systolic blood pressure; TIA, transient ischemic attack.